Niemann-Pick Disease, A Pipeline Analysis Report 2018
Por um escritor misterioso
Descrição
Technavio has published a new report on the drug development pipeline for Niemann-pick disease, including a study of the pipeline molecules.
Metabolic Therapeutics - Pharma Proff
The Pipeline Report 2013: Late-Stage Standouts - MM+M - Medical Marketing and Media
A validated analysis pipeline for mass spectrometry-based vitreous proteomics: new insights into proliferative diabetic retinopathy, Clinical Proteomics
Niemann-Pick disease type-B: a unique case report with compound heterozygosity and complicated lipid management, BMC Medical Genetics
Prader-Willi Syndrome, A Drug Pipeline Analysis Report 2018, Technavio
Global Niemann-Pick Disease Market and Competitive Landscape Research Report 2021: Pipeline, Epidemiology, Valuations, Drug Sales, Forecasts, and Market Shares, 2018-2026 - ResearchAndMarkets.com
IPO Launch: Orphazyme A/S Finalizes Terms For $100 Million U.S. IPO - IPOs On TheStreet - U.S. IPO Research & Opinion
Precision health in Alzheimer disease: Risk assessment‐based strategies - Azar - 2021 - Precision Medical Sciences - Wiley Online Library
Orphazyme's arimoclomol to be used with Zavesca after FDA approval
Global Niemann Pick Disease Type C Market to Surpass US$ 378.8 Million by 2027, Says Coherent Market Insights (CMI)
Developing an mRNA gene therapy for Niemann-Pick Disease Type C (NP-C), a childhood dementia, Research Project
ALK Inhibitors for Non-small Cell Lung Cancer, A Pipeline Analysis Report 2018, Technavio
MRx Pipeline July 2023 by Magellan Rx Management - Issuu
de
por adulto (o preço varia de acordo com o tamanho do grupo)
